Ryan Langston
Stock Analyst at TD Cowen
(0.30)
# 4,148
Out of 4,386 analysts
224
Total ratings
35.1%
Success rate
-6.2%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EHC Encompass Health | Initiated Coverage: Buy | $125 | $101.11 | +23.63% | 1 | May 29, 2026 | |
| HCA HCA Healthcare | Maintained: Buy | $500 | $361.32 | +38.38% | 13 | May 27, 2026 | |
| SGRY Surgery Partners | Maintained: Buy | $20 → $17 | $13.86 | +22.70% | 11 | May 27, 2026 | |
| PIII P3 Health Partners | Rated: Hold | $3 → $14 | $12.25 | +14.29% | 10 | May 22, 2026 | |
| ASTH Astrana Health | Reiterated: Buy | $35 → $45 | $38.39 | +17.22% | 12 | May 12, 2026 | |
| DVA DaVita | Rated: Hold | $144 → $201 | $192.08 | +4.64% | 11 | May 11, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | $30 | $21.41 | +40.12% | 12 | May 11, 2026 | |
| ADUS Addus HomeCare | Rated: Buy | $140 → $131 | $90.71 | +44.42% | 21 | May 8, 2026 | |
| CNC Centene | Rated: Hold | $38 → $47 | $65.03 | -27.73% | 16 | May 4, 2026 | |
| THC Tenet Healthcare | Rated: Buy | $242 | $163.01 | +48.46% | 7 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $15.35 | +62.87% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $173 → $211 | $355.98 | -40.73% | 14 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $245 → $230 | $142.87 | +60.99% | 15 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22 → $24 | $25.32 | -5.21% | 13 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $144 → $163 | $198.41 | -17.85% | 17 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 | $418.15 | -4.34% | 14 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $311 → $337 | $406.57 | -17.11% | 16 | Apr 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $95.33 | -84.27% | 8 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $400 → $391 | $289.61 | n/a | 3 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $7.34 | n/a | 1 | Aug 9, 2024 |
Encompass Health
May 29, 2026
Initiated Coverage: Buy
Price Target: $125
Current: $101.11
Upside: +23.63%
HCA Healthcare
May 27, 2026
Maintained: Buy
Price Target: $500
Current: $361.32
Upside: +38.38%
Surgery Partners
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $13.86
Upside: +22.70%
P3 Health Partners
May 22, 2026
Rated: Hold
Price Target: $3 → $14
Current: $12.25
Upside: +14.29%
Astrana Health
May 12, 2026
Reiterated: Buy
Price Target: $35 → $45
Current: $38.39
Upside: +17.22%
DaVita
May 11, 2026
Rated: Hold
Price Target: $144 → $201
Current: $192.08
Upside: +4.64%
Privia Health Group
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $21.41
Upside: +40.12%
Addus HomeCare
May 8, 2026
Rated: Buy
Price Target: $140 → $131
Current: $90.71
Upside: +44.42%
Centene
May 4, 2026
Rated: Hold
Price Target: $38 → $47
Current: $65.03
Upside: -27.73%
Tenet Healthcare
May 4, 2026
Rated: Buy
Price Target: $242
Current: $163.01
Upside: +48.46%
May 4, 2026
Rated: Buy
Price Target: $25
Current: $15.35
Upside: +62.87%
May 1, 2026
Rated: Hold
Price Target: $173 → $211
Current: $355.98
Upside: -40.73%
Apr 29, 2026
Rated: Buy
Price Target: $245 → $230
Current: $142.87
Upside: +60.99%
Apr 24, 2026
Reiterated: Buy
Price Target: $22 → $24
Current: $25.32
Upside: -5.21%
Apr 24, 2026
Rated: Hold
Price Target: $144 → $163
Current: $198.41
Upside: -17.85%
Apr 24, 2026
Maintained: Buy
Price Target: $400
Current: $418.15
Upside: -4.34%
Apr 23, 2026
Rated: Hold
Price Target: $311 → $337
Current: $406.57
Upside: -17.11%
Feb 27, 2026
Maintained: Hold
Price Target: $25 → $15
Current: $95.33
Upside: -84.27%
Nov 1, 2024
Maintained: Buy
Price Target: $400 → $391
Current: $289.61
Upside: n/a
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $7.34
Upside: n/a